Delivery Order SPE2DB22D1106-SPE2DB24FFHK6

Award Date 8/19/24
Potential Completion Date 8/20/24
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) pens. The contract has a firm fixed price of $1,480.09 and a period of performance through May 2025. The award is not set aside and represents an open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $32,685.47 firm-fixed-price contract is for the supply of HUMIRA(CF) PEN 80 MG/0.8 MLS, a pharmaceutical product. The award has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Humira (adalimumab) in a specialty injection pen format. The $33,306.55 firm fixed-price contract has a period of performance through November 2024 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,158.74 firm fixed-price contract is for the supply of the medication Humira (adalimumab) in a prefilled pen form. The contract has a performance period through July 2024 and is not a set-aside. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical for providing a wide range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) injector pens. The $3,496.44 firm-fixed-price contract has a completion date of September 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,549.45, is for the delivery of Humira (adalimumab) prefilled pens for the U.S. government, with an ultimate completion date of October 26, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) injection pens. The contract is a $6,538.28 firm-fixed-price delivery order with a completion date of September 6, 2024. The contract is not a set-aside award. AmerisourceBergen, through its Corporate Office division, will provide the Humira medication to support military treatment facilities and other government...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,980.64, is for the provision of Humira (adalimumab) pen medication. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) pens. The contract has a firm fixed price of $29,441.08 and a period of performance through April 26, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,770.74, is for the supply of Humira Pen, a specialty medication used in the treatment of various medical conditions. The contract is a firm-fixed-price delivery order with an ultimate completion date of April 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFHK6
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Humira (adalimumab) pens. The $22,850.20 firm fixed-price contract has an ultimate completion date of August 20, 2024. AmerisourceBergen is delivering this product under a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides a wide range of medical commodities to military treatment programs and facilities worldwide. This award is not associated with any set-aside program.

Generated 11/18/24, 9:44 AM